Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ireland
Ireland: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 81.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ireland, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Ireland stood at 81.0%.
That represents a change of down 3.6% on the previous year and down 12.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Ireland peaked at 92.0% in 2014 and was at its lowest, 0.0%, in 2008.
That places Ireland 113th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ireland, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 43.0% | — |
| 2011 | 90.0% | +109.3% |
| 2012 | 91.0% | +1.1% |
| 2013 | 91.0% | +0.0% |
| 2014 | 92.0% | +1.1% |
| 2015 | 92.0% | +0.0% |
| 2016 | 91.0% | -1.1% |
| 2017 | 91.0% | +0.0% |
| 2018 | 90.0% | -1.1% |
| 2019 | 86.0% | -4.4% |
| 2020 | 87.0% | +1.2% |
| 2021 | 85.0% | -2.3% |
| 2022 | 84.0% | -1.2% |
| 2023 | 83.0% | -1.2% |
| 2024 | 84.0% | +1.2% |
| 2025 | 81.0% | -3.6% |
Ireland compared with similar countries
- Ireland's 81.0% is below the median for high income countries, which is 91.0%, 89% of the median. (63 countries reporting)
- Ireland's 81.0% is below the median for Europe & Central Asia, which is 87.0%, 93% of the median. (51 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ireland changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +109.3% | 43.0% | 90.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 85.7% | 43.0% | 92.0% | 10 |
| 2020s | 84.0% | 81.0% | 87.0% | 6 |
Countries ranked near Ireland
More health data for Ireland
- Un projection of annual infant deaths, annual growth rate -4.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.89 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 20 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.7228 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.026 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6489 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Ireland?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Ireland was 81.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Ireland?
- The highest recorded value was 92.0% in 2014.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Ireland?
- The lowest recorded value was 0.0% in 2008.
- How does Ireland rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Ireland ranks 113th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Ireland?
- Over the last ten years it is down 12.0%. The long-run trend across the full record is rising.
- Where does this Ireland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).